Experimental oncology
1 – 10 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Systemic and local decorin levels mirror the clinical course of pancreatic cancer
- Contribution to journal › Article
- 2025
-
Mark
FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma
- Contribution to journal › Article
-
Mark
Evolutionary unpredictability in cancer model systems
- Contribution to journal › Article
-
Mark
An Activin Receptor-Like Kinase 1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases
- Contribution to journal › Article
-
Mark
Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties
- Contribution to journal › Article
-
Mark
Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines
- Contribution to journal › Article
- 2024
-
Mark
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma
- Contribution to journal › Article
-
Mark
Spatial multiomics reveal intratumoral immune heterogeneity with distinct cytokine networks in lung cancer brain metastases
- Contribution to journal › Article
-
Mark
Cancer-associated fibroblasts express CD1d and activate invariant natural killer T cells under cellular stress
- Contribution to journal › Letter
-
Mark
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
- Contribution to journal › Article
